Disease-modifying anti-osteoarthritic drugs: Current therapies and new prospects around protease inhibition

Farmaco

Volumn 56, Issue 1-2, 2001, Pages 107-112

  De Nanteuil, Guillaume ^a   Portevin, Bernard ^a   Benoist, Alain ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Osteoarthritis; Protease inhibitors; Proteases

Indexed keywords

ACETYLSALICYLIC ACID; AGGRECAN; ANATRIL; ASPARTIC PROTEINASE; CATHEPSIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; COLLAGEN; COLLAGEN FIBRIL; CYSTEINE PROTEINASE; DIACETYLRHEIN; ELASTASE; ELASTASE INHIBITOR; ENZYME INHIBITOR; ENZYME PRECURSOR; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN PEPTIDE; GLYCOSAMINOGLYCAN POLYSULFATE; IBUPROFEN; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; STROMELYSIN; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROKINASE;

ANTIINFLAMMATORY ACTIVITY; ARTICULAR CARTILAGE; CONFERENCE PAPER; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRINOLYSIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION;

CARTILAGE, ARTICULAR; CASPASE 1; CATHEPSIN B; CATHEPSIN D; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HUMANS; OSTEOARTHRITIS; PANCREATIC ELASTASE; PROTEASE INHIBITORS; THROMBIN;

EID: 0035272220     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01027-8     Document Type: Conference Paper

References (44)

1. Epidemiology, clinical course, and outcome of knee osteoarthritis
2. Mechanisms of joint destruction, pain and disability in osteoarthritis
3. Current pharmacological treatment of osteoarthritis
4. Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage
5. Antiarthritic effects of glucosamine sulfate studies on animal models
6. Histologic assessment of cathepsin D in osteoarthritic cartilage
7. Biochemical and histological changes in osteoarthritic synovial membrane
8. Acid, neutral and alkaline hydrolases in arthritic synovium
9. Augmented excretion of preprocathepsin L of a fos-transferred highly metastatic rat cell line
10. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization
11. Susceptibility of the cartilage collagens type II, IX and XI to degradation by the cysteine proteinases cathepsins B and L
12. Cathepsin B: an alternative protease for the generation of an aggrecan metalloproteinase cleavage neoepitope
13. Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Implication for treatment of rheumatoid arthritis
14. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant-induced arthritis
15. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases
16. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
17. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage
18. Involvement of thrombin on GAGS release in different cellular systems
19. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-Pa receptors on their surface
20. The synthesis of three 4-substituted benzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase
21. T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats
22. Modulators of plasminogen activator inhibitor-1 (PAI-1) activity
23. Hyaluronic acid inhibits the expression of u-Pa, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis
24. The possible role of neutrophil proteinases in damage to articular cartilage
25. Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146
26. Neutrophil-derived elastase and cartilage degradation
27. Interaction between neutrophil-derived elastase and reactive oxygen species in cartilage degradation
28. Dual inhibition of human leucocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo [2.2.2] octane and perhydroindole derivatives
29. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)
30. Disease modification by RS-130830, a collagenase-3 selective inhibitor, in experimental osteoarthritis (OA)